Neuroendoscopy - Market Insights, Competitive Landscape and Market Forecast-2030

Published Date : 2024
Pages : 150
Region : Global,
Delivery Timeline : 24 Hours

neuroendoscopy market market

"DelveInsight’s ‘Neuroendoscopy - Market Insight, Competitive Landscape and Market Forecast, 2030’ report delivers an in-depth understanding of Neuroendoscopy and the historical and forecasted Neuroendoscopy market trends, globally, which comprises of North America, Europe, APAC, and RoW.


The Neuroendoscopy market report provides an overview of Neuroendoscopy, applications of Neuroendoscopy as well as its advantages and limitations. Additionally, the report provides insight on the Neuroendoscopy market share by segments, along with assessment of market share by regions, the qualitative and quantitative (USD million, 2021-2030) data will be provided for all the segment in the scope. Moreover, the report also covers the market drivers, market challenges and restraints, and opportunities, along with the impact COVID-19 has had on this market. Assessment of Key 12-15 Players operating in the Neuroendoscopy market will be covered in-depth in the report comprising of company overview, financial overview, product overview and company share analysis of key 3-5 players. Additionally the PORTER’s analysis will also be provided to give an analytical edge to the Neuroendoscopy market report. 
 

Study Period: 2021-2030
 

Geography Covered

  • North America
  • The United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • The United Kingdom
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Rest of APAC
  • RoW
  • Middle East
  • Africa
  • South America
     

Neuroendoscopy - Competitive Analysis

This segment of the report provides a brief competitive analysis of Neuroendoscopy, to help understand the competition in the market. It gives a comparative understanding of the Key Companies in the market.
 

Recent Development

  • On October 21, 2026, SonoClear AS announced that the FDA had accepted its 510(k) submission for substantive review of the SonoClear System. The technology is an acoustic coupling fluid designed to improve intraoperative ultrasound imaging during brain tumour resection by reducing acoustic artefacts and improving visualization of the surgical cavity. The system had previously received FDA Breakthrough Device Designation, and its pivotal clinical study included 44 patients. This regulatory milestone advances the company's efforts toward potential US commercialization of its neurosurgical imaging technology.
  • On October 16, 2026, the FDA granted 510(k) clearance to VPIX Medical, Inc. for its cCeLL – In vivo device (K260315). The device was classified as a Class II neurological endoscope under product code GWG and regulation 21 CFR 882.1480. This regulatory milestone adds another device to the neurological endoscope category and reflects continued development of endoscopic visualization technologies for neurosurgical applications.
  • On October 14, 2026, the US FDA granted 510(k) clearance to KARL STORZ SE & Co. KG for its Flexible Video Neuro-Endoscope (K260581). The device is classified under the neurological endoscope category (21 CFR 882.1480), marking a relevant regulatory development in the neuroendoscopy market. The clearance supports the availability of another flexible neuroendoscopic visualization system for neurological applications.
  • On August 27, 2026, University College London Hospitals (UCLH) announced the first use of an AI system to support a neurosurgeon in real time during brain tumour surgery. The technology was developed at University College London and evaluated through a clinical trial. It analyzes live surgical video feeds to identify and highlight critical anatomical structures, particularly around the skull base, helping surgeons make more informed intraoperative decisions. This development highlights the potential application of real-time AI-based video analysis in advanced neurosurgical and endoscopic procedures.
  • On July 15, 2026, Mount Sinai initiated the MINUTE clinical trial (NCT07260916), evaluating minimally invasive neuroendoscopic ultra-early targeted evacuation of intracerebral haemorrhage. The multicentre, randomized controlled trial compares minimally invasive endoscopic SCUBA evacuation combined with standard medical management against standard medical management alone in patients with spontaneous basal ganglia haemorrhage. The trial evaluates treatment initiated within different time windows following symptom onset, including less than 8 hours and 8–16 hours. This clinical development highlights the growing application of neuroendoscopic techniques in minimally invasive haemorrhage management.
  • On June 4, 2026, the US FDA granted 510(k) clearance to Stryker Endoscopy for its Precision S 4K Sinuscope (K253602), classified under the neurological endoscope category (21 CFR 882.1480). The clearance represents a regulatory development in endoscopic visualization technology. Although primarily a sinus endoscope, the device's classification under the neurological endoscope category makes this development relevant to the broader endoscopic and skull-base surgical equipment landscape.
  • On June 3, 2026, Brain Navi Biotechnology announced that its KrystoLens single-use neuro-endoscope had received certification from the Taiwan Food and Drug Administration (TFDA). The device is designed to reduce cross-infection risks, improve ease of operation, and expand the surgical field of view. Following regulatory certification, the company planned to begin a full-scale commercial push in Taiwan during the second half of 2026, working with healthcare institutions and distribution partners to expand clinical adoption. This development represents a direct product-commercialization milestone in the neuroendoscopy market.
  • On May 12, 2026, SonoClear AS announced the completion of clinical enrollment for its SonoClear System, which has received FDA Breakthrough Device Designation. The system incorporates an acoustic coupling fluid designed to improve intraoperative ultrasound imaging during neurosurgical procedures. The technology aims to reduce acoustic artifacts that can obscure residual tumour tissue during surgery. Following completion of the final clinical procedure, the company moved toward data analysis and preparation for US marketing clearance. This development is relevant to the broader neurosurgical visualization market, including procedures involving neuroendoscopic assistance.
  • On May 12, 2026, Albany Medical Center announced the first clinical use of Medtronic's Stealth AXiS Surgical System for complex brain surgery. The procedure involved removing a pituitary tumour through the nasal passage using an endoscopic approach. The system uses artificial intelligence to map critical neural pathways and provides real-time, three-dimensional image-guided tracking of surgical instruments. This development demonstrates the increasing adoption of AI-powered navigation and visualization technologies in endoscopic skull-base and pituitary surgery.
  • On April 29, 2026, Medtronic announced the successful completion of its first clinical cases using the Stealth AXiS Surgical System following FDA clearances received in February and March 2026. The platform integrates AI-driven surgical planning, advanced navigation, and robotic guidance to support complex neurosurgical procedures. Its connected surgical ecosystem is designed to improve anatomical visualization, surgical planning, and intraoperative execution. The advancement represents progress in integrating intelligent navigation and robotic technologies into neurosurgical workflows, including complex skull-base procedures.
  • On March 27, 2026, Medtronic announced FDA clearance of its Stealth AXiS Surgical System for cranial and ear, nose, and throat procedures. The platform integrates surgical planning, navigation, robotics, and AI-enabled capabilities to support complex neurosurgical and minimally invasive skull-base procedures. Its AI-based automatic tractography helps surgeons generate patient-specific brain maps and visualize critical neural pathways, while its intraoperative imaging integration provides additional surgical guidance. This development strengthens the adoption of advanced navigation and visualization technologies in endoscopic skull-base surgery.
  • On March 18, 2026, XRlabs announced the first-in-human use of its real-time physical AI technology integrated with the ORBEYE 4K 3D exoscope during a neurosurgical procedure at Lenox Hill Hospital, New York. The platform, powered by NVIDIA Jetson Thor, processes live surgical video to support instrument tracking, surgical scene recognition, and voice-responsive automation. The technology aims to improve intraoperative visualization and situational awareness without modifying the existing exoscope hardware. Although developed for broader neurosurgical applications rather than neuroendoscopy specifically, this advancement highlights the growing integration of AI-powered visualization into surgical environments.
  • On March 11, 2026, Brain Navi Biotechnology announced that its NaoTrac neurosurgical navigation robot had received medical device approval from India's Central Drugs Standard Control Organization (CDSCO). The regulatory milestone supports the company's expansion into the Indian neurosurgical technology market. NaoTrac is designed to assist surgeons in image-guided neurosurgical procedures, including brain biopsies, through robotic navigation and precision guidance. Although not a neuroendoscope itself, the technology represents an adjacent development in advanced neurosurgical navigation and minimally invasive surgical workflows.
  • On February 17, 2026, a surgical team from the University of Pittsburgh and UPMC successfully performed the first endoscopic endonasal skull-base procedure using mixed reality integrated into the surgical workflow. The procedure involved the removal of a pituitary tumour and was performed at UPMC Presbyterian Hospital. The technology integrates mixed-reality visualization into endoscopic surgery, allowing surgeons to use advanced visual guidance while operating through the nasal corridor. This milestone highlights the growing integration of augmented and mixed-reality technologies into minimally invasive neuroendoscopic procedures.

Neuroendoscopy: Market Analysis

This segment illustrates the global market of Neuroendoscopy along with the market segmentation. Furthermore, the Neuroendoscopy market report will provide the regional level cross-segmentation quantitative data. Moreover, the assessment is done on how the market is expected to rise in the study period (2021 to 2030), at a significant CAGR.
 

KOL- Views
To keep up with the market trends, we take KOLs and SME’s opinion working in Neuroendoscopy domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging Neuroendoscopy market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
 

Scope of the Report

  • The report covers the descriptive overview of Neuroendoscopy, explaining its applications, advantages, and limitations, etc.
  • Additionally, detailed profiles of the Key Companies operating in the market is provided, along with the market share of the Key 3-5 players.
  • A detailed review of Neuroendoscopy market; historical and forecasted market size is included in the report, covering global outreach.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Neuroendoscopy market.
     

Report Highlights

  • The report also reviews the detailed global historical and forecasted Neuroendoscopy market including assessing the outreach in America, Europe, APAC, and Rest of World (RoW).
  • The report helps in developing business strategies by understanding trends shaping and driving the global Neuroendoscopy market.
  • The impact of COVID-19 on the Neuroendoscopy market will be discussed in detail in the report.
     

Neuroendoscopy Report Key Strengths

  • 5 Years Forecast
  • Global Coverage
  • Competitive Landscape
  • Neuroendoscopy Market Size
  • Neuroendoscopy Market Segmentation
  • Neuroendoscopy Market Company Profiles
  • Neuroendoscopy Market PORTER’s Five Forces Analysis
  • Neuroendoscopy Market Company Share Analysis (Key 3-4 players)

Neuroendoscopy Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views

Key Takeaways from the Neuroendoscopy Market Report Study

  • Neuroendoscopy Market size analysis for current market (2023), and Neuroendoscopy market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on Neuroendoscopy market is significant. To capture and analyze suitable indicators, our experts are closely watching the Neuroendoscopy market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years in Neuroendoscopy market.
  • Key companies dominating the Global Neuroendoscopy Market.
  • Various opportunities available for the other competitor in the Neuroendoscopy Market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current Neuroendoscopy market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Neuroendoscopy market growth in the coming future?

Target Audience who can benefit from Neuroendoscopy Market Report Study

  • Neuroendoscopy providers
  • Research organizations and consulting companies 
  • Neuroendoscopy related organization, association, forum, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders in Neuroendoscopy market
  • Various End-users who want to know more about the Neuroendoscopy Market and latest technological developments in the Neuroendoscopy market.

Tags:

  • medical device

Related Reports

report image delveinsight

Continuous Renal Replacement Therapy Machines Market Insights, Competitive Landscape, and Market Forecast - 2034

report image delveinsight

Advanced Wound Care Market Insights, Competitive Landscape, and Market Forecast - 2034

report image delveinsight

Defibrillator Market Insights, Competitive Landscape, and Market Forecast - 2034

report image delveinsight

Vagus Nerve Stimulator (VNS) - Global Market Insights, Competitive Landscape, and Market Forecast - 2030

License Type


Offer

Request Sample

View Pricing

Customize Reports As Per Your Needs

Don't see what you're looking for? Get a report tailored to your specific requirements. Customize your report now!

Have a Question?

We are happy to assist you.

DelveInsight
DelveInsight
SUBSCRIPTION
Platform

Register for free trial today and gain instant access to 7000+ market
research reports